Chun Kwok Alan Au CPA serves as Independent Director of the Company. Mr. Au has over 18 years of experience across healthcare investment banking, private equity and venture capital investments in Asia/China. He is Founder/Managing Partner at GT Healthcare Group, a private equity fund focusing on cross border healthcare investments founded in 2015. Mr. Au was an Adviser to Simcere Pharmaceutical Group, a leading pharmaceutical company in China (previously listed on NYSE: SCR, privatized in Dec 2013, when Mr. Au was Chairman of the Special Committee of the Board ) from 2013 to 2014. He was also a member of the Board, Audit Committee and Compensation Committee of China Nepstar Chain Drugstore Ltd. (NYSE: NPD, privatized in Sep 2016) from 2013 to 2016. Mr. Au also serves as a panel member for the Entrepreneur Support Scheme (ESS Program) of the Innovation and Technology Fund of the Hong Kong SAR Government since 2014. Mr. Au is a Certified Public Accountant in the U.S. and holds the Chartered Financial Analyst (CFA) designation. He is an associate member of the Hong Kong Institute of Financial Analysts and member of the American Institute of Certified Public Accountants. Mr. Au received his Bachelor’s degree in Psychology from the Chinese University of Hong Kong, and a Master’s degree in Management from Columbia Business School in New York. In considering Mr. Au’s eligibility to serve on the Board, the Board considered Mr. Au’s investment banking and capital markets experience, as well as healthcare and pharmaceutical industry specific expertise.
As the Independent Director of Cellular Biomedicine Inc, the total compensation of Chun Au at Cellular Biomedicine Inc is $120,878. There are 6 executives at Cellular Biomedicine Inc getting paid more, with Andrew Chan having the highest compensation of $847,684.
Chun Au is 47, he's been the Independent Director of Cellular Biomedicine Inc since 2014. There are 7 older and 2 younger executives at Cellular Biomedicine Inc. The oldest executive at Cellular Biomedicine Group Inc is Edward Schafer, 74, who is the Non-Executive Independent Director.
Chun's mailing address filed with the SEC is 19925 Stevens Creek Blvd #100, Cupertino, CA 95014, USA.
Over the last 13 years, insiders at Cellular Biomedicine Inc have traded over $5,441,696 worth of Cellular Biomedicine Inc stock and bought 262,367 units worth $1,621,804 . The most active insiders traders include Keith Wong, Wei (William) Cao a Pak To Venture Garden Ltd F.... On average, Cellular Biomedicine Inc executives and independent directors trade stock every 84 days with the average trade being worth of $911,976. The most recent stock trade was executed by Wen Tao Liu on 10 April 2018, trading 22,444 units of CBMG stock currently worth $348,555.
Cellular Biomedicine Inc executives and other stock owners filed with the SEC include: